Psilotec Health, operating as Zylorion, has announced that it has received approval from the Health Research Ethics Board of Alberta to conduct a phase II clinical study for patients suffering from treatment-resistant depression.
Category Press Release
Published in Biospace
Companies Featured
Psilotec Health SolutionsPsilotec aims to produce psilocybin-containing mushrooms and train therapists to treat mental health disorders.